Custom Lucite commemorating seed financing for Martin Pharmaceuticals. The design replicates the packaging for LIVANTRA, an orphan drug for the treatment of Acute-on-Chronic Liver Failure (ACLF). (8AMF069)
Custom Lucite commemorating seed financing for Martin Pharmaceuticals. The design replicates the packaging for LIVANTRA, an orphan drug for the treatment of Acute-on-Chronic Liver Failure (ACLF). (8AMF069)
Lucite deal tombstone commemorating the sale of over-the-counter
(OTC brand Zegerid. Zegerid is a treatment for frequent heartburn. 22AJH015)Lucite tombstone commemorating a joint venture between pharmaceutical firms Pfizer and GlaxoSmithKline. The joint venture centers on the over-the-counter consumer healthcare business.
(9AKL489)Custom financial tombstone recognizing a direct offering of common stock by Salarius Pharmaceuticals. The Houston-based firm develops cancer therapies. (22AJH070)
Crystal commemorative marking a licensing and commercialization agreement between Corbus Pharmaceuticals and CSPC Pharmaceutical Group. The agreement centers on a potential treatment for tumors associated with lung, breast, and prostate cancers. (23AZH089)
Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)
Custom Lucite recognizing Swedish-based pharmaceutical firm Meda’s acquisition of several consumer brands from GlaxoSmithKline, headquartered in Brentford, England. GlaxoSmithKline was advised in the transaction by Sawaya Segalas, a firm based in New York City.
